);

News & Insights

acorn-regulatory-industry-news-roundup

Industry News Roundup: October

In between constantly managing regulatory affairs submissions for our clients and dealing with some of the most dynamic healthcare companies […]

Outsourcing Regulatory Affairs

Benefits of Outsourcing Regulatory Affairs

The developments in the market, mergers and the issues associated with pricing pressures applied by governments (such as the IPHA […]

Find Out More About Acorn Regulatory's Pharmacovigilance Services

Find Out More About Acorn Regulatory’s Pharmacovigilance Services

Right now, we are working as the ‘virtual pharmacovigilance office’ for many of the most dynamic healthcare manufacturers in the […]

Acorn Regulatory ISO 9001 2015

Changes to ISO 9001

At Acorn Regulatory we are committed to ensuring quality in all aspects of what we do so it’s vital to […]

Acorn Regulatory - Industry Bodies Come Together To Host BioPharma Ambition Conference in Dublin

Industry Bodies Come Together To Host BioPharma Ambition.

Minister Simon Harris’ confirmation that the Irish government will soon be making a bid to be the new home of […]

acorn regulatory affairs newsletter

Acorn Regulatory Monthly Newsletter: September 2016

We have just launched our new Acorn Regulatory monthly newsletter.  You can read all of the stories from the newsletter […]

Implications of Brexit

The Implications of Brexit for the Life Sciences Sector

The implications of Brexit are still being felt.  Politically, the decision has triggered a chain of events that none of us […]

USA Canada align submission gateways regulatory applications regulatory submissions

Get The Industry News Roundup for September

In this month’s roundup of industry news roundup, we will be looking at how the USA and Canada are working […]

Acorn Regulatory work on site with our client in the south east of Ireland

Work On-Site With Our Client in the South-East of Ireland

Right now, we are seeking a consultant to work on-site with our client in the south-east of Ireland. The client is […]

Brexit Medical Device

Implications of Brexit for the Medical Device Sector

In this extract from our first Brexit whitepaper, written in July 2016, we look at the implications of Brexit for […]

EU GVP

EMA Introduces New Chapter on Good Pharmacovigilance Practices (EU-GVP)

The European Medicines Agency has added a new chapter (Product- or population-specific considerations II: Biological medicinal products) to its guidelines […]

Life Sciences Brexit

Brexit Clinical Trials Sector Implications

In this extract from our first Brexit whitepaper we look at the implications of Brexit for the clinical trials sector.

Contact us and enjoy a faster, smoother journey through the maze of European Pharmaceutical and Medical Device legislation with us as your expert guide.
©2019 Acorn Regulatory Consultancy Services Ltd. Company Registration No. 397294 VAT Registered No. IE 6417294V
Designed by